7Bhatia J. Current option in the management of apnea of prematurity [J]. Clin Pediatr. 2000, 39(6) :327-336.
8Lee TC, Charles B, Steer P, et al. Population pharmacokinetics of intravenous caffeine in apnea of prematurity [J]. Clin Pharmacol Ther, 1997, 61:628-640.
9Erenberg A, Leff R, Wynne B, et al. Results of the first double-blind placebo-controlled study of caffeine citrate for the treatment of apnea of prematurity(AOP) [J]. Pediatr. 1998, 102:756-757.
10Comer AM, Perry CM, Figgitt DP. Caffeine citrate: a review of its use in apnea of prematurity [J]. Paediatr Drugs. 2001, 3(1):61-79.
8Pavcnik D,Takulve K,Uchida BT. Biodisk:a new device forclosure of patent foramen ovale:a feasibility study in swine[J].{H}Catheterization and Cardiovascular Interventions,2010,(6):861-867.
9Schmidt B,Roberts RS,Davis P. Long-term effects of caffeine therapy for apnea of prematurity[J].{H}New England Journal of Medicine,2007,(19):1893-1902.
